sclareol has been researched along with Liver Cirrhosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, YY; Ge, MX; He, HW; Lu, ZN; Niu, WX | 1 |
1 other study(ies) available for sclareol and Liver Cirrhosis
| Article | Year |
|---|---|
Sclareol attenuates liver fibrosis through SENP1-mediated VEGFR2 SUMOylation and inhibition of downstream STAT3 signaling.
Topics: Animals; Fibrosis; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Mice; Rats; Signal Transduction; Sumoylation | 2023 |